This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Jeong Ho Lee of KAIST receives the 2015 Pediatric Epilepsies Research Award

September 10th, 2015

The Citizen United for Research in Epilepsy (CURE) announced on September 7, 2015, that Jeong Ho Lee, a professor of the Graduate School of Medical Science and Engineering at KAIST (Korea Advanced Institute of Science and Technology), will be awarded the 2015 Pediatric Epilepsies Research Award.

The Pediatric Epilepsies Research Award is given annually to a researcher who has conducted novel, innovative research projects that address severe, intractable pediatric epilepsies as well as collaborative, interdisciplinary projects that explore new approaches to find a treatment for pediatric epilepsies.

Lee was recognized for his leading study in the field of intractable epilepsy. He is the first Korean who has ever received this award, securing a research grant of USD 250,000 for two years.

Lee has conducted research on brain somatic mutations as the novel cause of childhood intractable epilepsy. Pediatric epilepsies account for approximately 70% of all cases of epilepsy.

Established in 1998, CURE is a non-profit American organization based in Chicago, Illinois, which is committed to funding research and various initiatives that will lead to breakthroughs to cure epilepsy.

Since its inception, CURE has been at the forefront of epilepsy research, raising more than USD 32 million to support researchers and scientists worldwide. It has also awarded more than 180 cutting-edge projects in 13 countries.

Provided by The Korea Advanced Institute of Science and Technology (KAIST)

Citation: Jeong Ho Lee of KAIST receives the 2015 Pediatric Epilepsies Research Award (2015, September 10) retrieved 10 May 2024 from https://sciencex.com/wire-news/203336438/jeong-ho-lee-of-kaist-receives-the-2015-pediatric-epilepsies-res.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.